Cardura Tablet
Product Images NDC 58151-075

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cardura (NDC 58151-075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viatris Specialty Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxazosin Mesylate Structural Formula (Image 01)

Doxazosin Mesylate Structural Formula (Image 01)
Chemical structure of doxazosin mesylate, the active ingredient in Cardura tablets by Viatris Specialty LLC.*
FDA Label Image

Table 3. (Image 02)

Table 3. (Image 02)
A bar chart comparing the symptom score and maximum flow rate changes across three placebo-controlled trials of Cardura (doxazosin) tablets at 4 mg and 8 mg doses versus placebo. The chart illustrates mean baseline and change values in symptom score and maximum flow rate, showing numerical improvements for Cardura in multiple dose groups over placebo.*
FDA Label Image

Figure 1 – Study 1 (Image 03)

Figure 1 – Study 1 (Image 03)
Two line graphs showing the effects of Cardura (doxazosin) versus placebo over 14 weeks. The first graph depicts mean change in total symptom score from baseline, with Cardura showing greater symptom reduction. The second graph shows mean increase in maximum urinary flow rate, with Cardura demonstrating higher improvement compared to placebo.*
FDA Label Image

Cardura (doxazosin) Tablets 1 mg Bottle Label (Image 04)

Cardura (doxazosin) Tablets 1 mg Bottle Label (Image 04)
Label for Cardura (doxazosin) tablets, 1 mg strength. The packaging indicates 100 tablets in the bottle, labeled for prescription use only. The product is distributed by Viatris Specialty LLC in Morgantown, WV. Storage instructions and labeling details are also visible.*
FDA Label Image

Cardura (doxazosin) Tablets 2 mg Bottle Label (Image 05)

Cardura (doxazosin) Tablets 2 mg Bottle Label (Image 05)
Label for Cardura (doxazosin) 2 mg oral tablets, distributed by Viatris Specialty LLC. The label indicates a 100-tablet package, prescription only, with storage instructions and manufacturer details. The label also includes the NDC, barcode, and batch identification.*
FDA Label Image

Cardura (doxazosin) Tablets 4 mg Bottle Label (Image 06)

Cardura (doxazosin) Tablets 4 mg Bottle Label (Image 06)
Cardura 4 mg tablets bottle label showing the brand and generic names (doxazosin), strength (4 mg), quantity (100 tablets), and the labeler (Viatris Specialty LLC). The label includes storage instructions, NDC number 58151-076-01, and notes the product is for prescription use only.*
FDA Label Image

Cardura (doxazosin) Tablets 8 mg Bottle Label (Image 07)

Cardura (doxazosin) Tablets 8 mg Bottle Label (Image 07)
Label for Cardura 8 mg tablets containing doxazosin. The label indicates 100 tablets in the package, prescription only, distributed by Viatris Specialty LLC, Morgantown, WV. Storage instructions specify 25°C (77°F) with permitted excursions from 15°C to 30°C (59°F to 86°F). The label also notes that each tablet contains doxazosin mesylate equivalent to 8 mg doxazosin as a free base.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.